Archives for August 30, 2006

← 2006

Synteract scores contract for brain cancer trial

By  Kirsty Barnes

California-based Synteract has scored a clinical trial management contract from Northwest Biotherapeutics to bring one of the world's first personalised medicines into a late stage clinical trial.

Troubled SFBC changes its name in hope of changing its fortunes

By  Kirsty Barnes

Large global contract research organisation, SFBC International, has changed its name to PharmaNet Development Group in a bid to make a fresh start and turnaround the troubled business after a long period of bad press, legal difficulties and poor...

IMA's order book packs in more sales

By  Gregory Roumeliotis

The recovery that has taken packaging and processing machinery company IMA to profitability in 2006 has continued, helped by new opportunities in the biotech sector and a strong growth in generics.

ZymoGenetics stings Bristol-Myers Squibb with patent lawsuit

By  Gregory Roumeliotis

Seattle drug firm ZymoGenetics has taken Bristol-Myers Squibb (BMS) to court for infringement of its fusion protein technology patents by several products, including arthritis medication Orencia (abatacept).